The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder

Acta Psychiatrica Scandinavica

Volumn 128, Issue 5, 2013, Pages 362-369

  Soeiro de Souza, M G ^a   Bio, D S ^a   Dias, V V ^b   Vieta, E ^c   Machado Vieira, R ^a   Moreno, R A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; CACNA1C; Calcium channel; Cognition; Depression; Executive function; Mania

Indexed keywords

L TYPE VOLTAGE GATED CALCIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ALLELE; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; EXECUTIVE FUNCTION; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE;

BIPOLAR DISORDER; CACNA1C; CALCIUM CHANNEL; COGNITION; DEPRESSION; EXECUTIVE FUNCTION; MANIA;

ADOLESCENT; ADULT; ALLELES; BIPOLAR DISORDER; CALCIUM CHANNELS, L-TYPE; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; RISK; YOUNG ADULT;

EID: 84885387509     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12073     Document Type: Article

References (49)

1. Machado-Vieira R, Pivovarova NB, Stanika RI et al. The Bcl-2 gene polymorphism rs956572AA increases inositol 1, 4, 5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder. Biol Psychiatry 2011;69:344-352.
2. Akimoto T, Kusumi I, Suzuki K, Koyama T. Effects of calmodulin and protein kinase C modulators on transient Ca2 + increase and capacitative Ca2 + entry in human platelets: relevant to pathophysiology of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:136-141.
3. Kato T. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium 2008;44:92-102.
4. Sourial-Bassillious N, Rydelius P-A, Aperia A, Aizman O. Glutamate-mediated calcium signaling: a potential target for lithium action. Neuroscience 2009;161:1126-1134.
5. Sklar P, Smoller JW, Fan J et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008;13:558-569.
6. Ferreira MAR, O'donovan MC, Meng YA et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008S;40:1056-1058.
7. Liu Y, Blackwood DH, Caesar S et al. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 2011;16:2-4.
8. Psychiatric Gwas Consortium Bipolar Disorder Working Group, Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011;43:977-983.
9. Shinnick-Gallagher P, Mckernan MG, Xie J, Zinebi F. L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning. Ann N Y Acad Sci 2003;985:135-149.
10. Bigos KL, Mattay VS, Callicott JH et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 2010S;67:939-945.
11. Kempton MJ, Ruberto G, Vassos E et al. Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry 2009;166:1413-1414.
12. Solé B, Martínez-Arán A, Torrent C et al. Are bipolar II patients cognitively impaired? a systematic review. Psychol Med 2011;41:1791-1803.
13. Thompson JM, Gallagher P, Hughes JH et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005;186:32-40.
14. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002;72:209-226.
15. Savitz J, Solms M, Ramesar R. Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 2005;7:216-235.
16. Balanzá-Martínez V, Rubio C, Selva-Vera G et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev 2008;32:1426-1438.
17. Glahn DC, Almasy L, Barguil M et al. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry 2010;67:168-177.
18. Bora E, Yücel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009;113:1-20.
19. Wang F, Mcintosh AM, He Y, Gelernter J, Blumberg HP. The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disord 2011;13:696-700.
20. Franke B, Vasquez AA, Veltman JA, Brunner HG, Rijpkema M, Fernández G. Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biol Psychiatry 2010;68:586-588.
21. Perrier E, Pompei F, Ruberto G, Vassos E, Collier D, Frangou S. Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. Eur Psychiatry 2011;26:135-137.
22. Wessa M, Linke J, Witt SH et al. The CACNA1C risk variant for bipolar disorder influences limbic activity. Mol Psychiatry 2010;15:1126-1127.
23. Jogia J, Ruberto G, Lelli-Chiesa G et al. The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol Psychiatry 2011;16:1070-1071.
24. Erk S, Meyer-Lindenberg A, Schnell K et al. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 2010;67:803-811.
25. Thimm M, Kircher T, Kellermann T et al. Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychol Med 2011;41:1551-1561.
26. Krug A, Nieratschker V, Markov V et al. Effect of CACNA1C rs1006737 on neural correlates of verbal fluency in healthy individuals. Neuroimage 2010;49:1831-1836.
27. Roussos P, Giakoumaki SG, Georgakopoulos A, Robakis NK, Bitsios P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord 2011;13:250-259.
28. Hori H, Yamamoto N, Fujii T et al. Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals. Sci Rep 2012;2:634.
29. Zhang Q, Shen Q, Xu Z et al. The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder. Neuropsychopharmacology 2012;37:677-684
30. Arts B, Simons CJP, Os JV. Evidence for the impact of the CACNA1C risk allele rs1006737 on 2-year cognitive functioning in bipolar disorder. Psychiatr Genet 2013;23:41-42.
31. Soeiro De Souza MG, Otaduy MCG, Dias CZ, Bio DS, Machado-Vieira R, Moreno RA. The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. J Affect Disord 2012;141:94-101.
32. First MB, Spitzer RL, Williams JB. Structured clinical interview for DSM-IV axis I disorders SCID-I. Washington, DC: American Psychiatric Press, 1996.
33. DSM-IV PATFO. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Publishing Inc, 2000.
34. Campos RN, Costa LF, Bio DS et al. LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder. Trials 2010;11:72.
35. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-62.
37. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33. quiz 34-57.
38. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests. New York: Oxford University Press, 2006.
39. Wechsler D. Wechsler abbreviated scale of intelligence. New York: Psychological Corporation, 1999.
40. Wechsler D. Wechsler adult intelligence scale-revised. San Antonio: The Psychological Corporation, 1981.
41. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 2004.
42. Laitinen J, Samarut J, Hölttä E. A nontoxic and versatile protein salting-out method for isolation of DNA. Biotechniques 1994;17:316-22.
43. Wang K, Zhang H, Ma D et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009;459:528-33.
44. Gargus JJ. Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism. Ann N Y Acad Sci 2009;1151:133-56.
45. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O'donovan MC et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009;460:748-52.
46. Sklar P, Gabriel SB, Mcinnis MG et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002;7:579-93.
47. Shifman S, Bronstein M, Sternfeld M et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004;128B:61-4.
48. Soeiro de Souza MG, Machado-Vieira R, Soares Boi D, Do Prado CM, Moreno RA. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder. Bipolar Disord 2012;14:554-64.
49. Arts B, Jabben N, Krabbendam L, Van Os J. A 2-year naturalistic study on cognitive functioning in bipolar disorder. Acta Psychiatr Scand 2011;123:190-205.